These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


443 related items for PubMed ID: 18376234

  • 1. A retrospective study of bifractionated CPT-11 with LF5FU infusion (FOLFIRI-3) in colorectal cancer patients pretreated with oxaliplatin and CPT-11 containing chemotherapies.
    Viel E, Demarchi MF, Chaigneau L, Nguyen T, Legat C, Stein U, Thiery-Vuillemin A, Limat S, Pivot X, Borg C.
    Am J Clin Oncol; 2008 Feb; 31(1):89-94. PubMed ID: 18376234
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
    Taïeb J, Artru P, Paye F, Louvet C, Perez N, André T, Gayet B, Hebbar M, Goebel FM, Tournigand C, Parc R, de Gramont A.
    J Clin Oncol; 2005 Jan 20; 23(3):502-9. PubMed ID: 15659495
    [Abstract] [Full Text] [Related]

  • 4. Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer.
    Chau I, Webb A, Cunningham D, Hill M, Waters JS, Norman A, Massey A.
    Br J Cancer; 2001 Nov 02; 85(9):1258-64. PubMed ID: 11720458
    [Abstract] [Full Text] [Related]

  • 5. Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study.
    François E, Berdah JF, Chamorey E, Lesbats G, Teissier E, Codoul JF, Badetti JL, Hébert C, Mari V.
    Cancer Chemother Pharmacol; 2008 Nov 02; 62(6):931-6. PubMed ID: 18273618
    [Abstract] [Full Text] [Related]

  • 6. Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure.
    Boige V, Malka D, Elias D, Castaing M, De Baere T, Goere D, Dromain C, Pocard M, Ducreux M.
    Ann Surg Oncol; 2008 Jan 02; 15(1):219-26. PubMed ID: 17896145
    [Abstract] [Full Text] [Related]

  • 7. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
    Fuchs CS, Marshall J, Mitchell E, Wierzbicki R, Ganju V, Jeffery M, Schulz J, Richards D, Soufi-Mahjoubi R, Wang B, Barrueco J.
    J Clin Oncol; 2007 Oct 20; 25(30):4779-86. PubMed ID: 17947725
    [Abstract] [Full Text] [Related]

  • 8. A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer.
    Kim SG, Oh SY, Kwon HC, Lee S, Kim JH, Kim SH, Kim HJ.
    Jpn J Clin Oncol; 2007 Oct 20; 37(10):744-9. PubMed ID: 17923456
    [Abstract] [Full Text] [Related]

  • 9. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec 20; 14(80):230-3. PubMed ID: 16400749
    [Abstract] [Full Text] [Related]

  • 10. Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).
    Hebbar M, Tournigand C, Lledo G, Mabro M, André T, Louvet C, Aparicio T, Flesch M, Varette C, de Gramont A, Oncology Multidisciplinary Research Group (GERCOR).
    Cancer Invest; 2006 Mar 20; 24(2):154-9. PubMed ID: 16537184
    [Abstract] [Full Text] [Related]

  • 11. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
    Del Freo A, Fiorentini G, Sanguinetti F, Muttini MP, Pennucci C, Mambrini A, Pacetti P, Della Seta R, Lombardi M, Torri T, Cantore M.
    In Vivo; 2006 Mar 20; 20(6A):743-6. PubMed ID: 17203759
    [Abstract] [Full Text] [Related]

  • 12. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
    Nobili S, Checcacci D, Filippelli F, Del Buono S, Mazzocchi V, Mazzei T, Mini E.
    J Chemother; 2008 Oct 20; 20(5):622-31. PubMed ID: 19028627
    [Abstract] [Full Text] [Related]

  • 13. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
    Novarino A, Satolli MA, Chiappino I, Giacobino A, Bellone G, Rahimi F, Milanesi E, Bertetto O, Ciuffreda L.
    Am J Clin Oncol; 2009 Feb 20; 32(1):44-8. PubMed ID: 19194124
    [Abstract] [Full Text] [Related]

  • 14. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
    Tsutsumi S, Yamaguchi S, Tsuboi K, Fukasawa T, Tabe Y, Asao T, Kuwano H.
    Hepatogastroenterology; 2008 Feb 20; 55(85):1419-22. PubMed ID: 18795703
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer.
    Cao W, Yang W, Lou G, Jiang J, Geng M, Xi W, Li H, Ma T, Jin Y.
    Anticancer Drugs; 2009 Apr 20; 20(4):287-93. PubMed ID: 19177020
    [Abstract] [Full Text] [Related]

  • 16. A phase II trial of modified FOLFOX as first-line chemotherapy in advanced colorectal cancer.
    Xiong JP, Zhang L, Zhong LX, Qiu F, Xu J, Tao QS, Xiang XJ, Yu F, Tang XM.
    Anticancer Drugs; 2007 Oct 20; 18(9):1103-7. PubMed ID: 17704661
    [Abstract] [Full Text] [Related]

  • 17. Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer.
    Teufel A, Steinmann S, Siebler J, Zanke C, Hohl H, Adami B, Schroeder M, Klein O, Höhler T, Galle PR, Heike M, Moehler M.
    BMC Cancer; 2004 Jul 20; 4():38. PubMed ID: 15265233
    [Abstract] [Full Text] [Related]

  • 18. [IFL].
    Yamazaki K, Yoshino T, Boku N.
    Gan To Kagaku Ryoho; 2006 Jul 20; 33(7):907-10. PubMed ID: 16835478
    [Abstract] [Full Text] [Related]

  • 19. [Clinical study of irinotecan plus infusional fluorouracil/l-leucovorin (FOLFIRI) in patients with fluoropyrimidine-resistant metastatic colorectal cancer].
    Moriwaki T, Hyodo I, Nishina T, Kajiwara T, Kataoka J, Hori S, Nasu J, Imamine S, Iguchi H.
    Gan To Kagaku Ryoho; 2007 Dec 20; 34(13):2249-53. PubMed ID: 18079624
    [Abstract] [Full Text] [Related]

  • 20. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H, Ozaki T, Shiina M.
    Cardiovasc Intervent Radiol; 2009 Jul 20; 32(4):679-86. PubMed ID: 19296157
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.